Company Presentation
NMD Pharma brænder 41 mio. kr. af sin kæmpeinvestering
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
Management — NMD Pharma
NMD Pharma - PIR International
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Tunge pengetanke klar til nye investeringer i biotekselskab fra Aarhus
NMD Pharma
Investors — NMD Pharma
Big deal: NMD flexes series A muscles - Global University Venturing
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
Management — NMD Pharma
Contact — NMD Pharma
NMD Pharma
NMD Pharma
NMD Pharma A/S | LinkedIn
Prominent Canadian researcher in Denmark: Why I left a top job in California
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma - Capnova
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma company information, funding & investors | Dealroom.co
Company Presentation
NMD Pharma company information, funding & investors | Dealroom.co
Company Presentation
NMD Pharma company information, funding & investors | Dealroom.co
